Trend changes of national zolpidem users and exposure cases after FDA drug safety communications.

Esther H Zhou Zhou Feng Ellen PinnowJoann LeeDaniel BakTravis ReadyGerald J Dal Pan

Published in: Pharmacoepidemiology and drug safety (2021)

Zolpidem users and exposure cases decreased significantly post-DSC, suggesting practitioners and patients became aware of and responded to the zolpidem DSCs.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
primary care
prognostic factors
peritoneal dialysis
quality improvement
general practice
electronic health record